Showing results (321-330 of 479) with videos related to
Sort By:
Pageof 48
The Journal of Biological Chemistry|March 30, 2001
Activation of the phosphatidylinositol 3-kinase/Akt pathway protects against interleukin-3 starvation but not DNA damage-induced apoptosisA L Mathieu, S Gonin, Y Leverrier, et al.Head & Neck|September 1, 1996
Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancerM J Zelefsky, D H Kraus, D G Pfister, et al.International Journal of Radiation Oncology, Biology, Physics|November 6, 2007
Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacyMichelle L Klem, James G Mechalakos, Suzanne L Wolden, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2002
Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intentIman Osman, Eric Sherman, Bhuvanesh Singh, et al.Journal of the American Medical Informatics Association : JAMIA|July 28, 2025
Real-world evaluation of user engagement with an artificial intelligence-powered clinical trial application in oncologyTony K W Hung, Jun J Mao, Alan L Ho, et al.Cancer Chemotherapy and Pharmacology|January 1, 1997
Selective inhibition of oncogenic ras-p21 in vivo by agents that block its interaction with jun-N-kinase (JNK) and jun proteins. Implications for the design of selective chemotherapeutic agentsS Amar, A Glozman, D Chung, et al.British Medical Journal (Clinical Research Ed.)|February 20, 1982
Outcome of endoscopy and barium radiography for acute upper gastrointestinal bleeding: controlled trial in 1037 patientsM W Dronfield, M J Langman, M Atkinson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2019
Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic CarcinomaVatche Tchekmedyian, Eric J Sherman, Lara Dunn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinomaR J Wong, D T Lin, H Schöder, et al.The American Journal of Pathology|August 7, 2002
Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomasBhuvanesh Singh, Archontoula Stoffel, Swarna Gogineni, et al.Pageof 48